Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Cancer and kinases: reports from the front line.

Burley SK.

Genome Biol. 2006;7(4):314. Epub 2006 Apr 25. No abstract available.

PMID:
16677415
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Small molecule inhibitors of protein kinases in cancer- how to overcome resistance.

Griffith R, Brown MN, McCluskey A, Ashman LK.

Mini Rev Med Chem. 2006 Oct;6(10):1101-10. Review.

PMID:
17073710
[PubMed - indexed for MEDLINE]
3.

Acquired resistance to tyrosine kinase inhibitors during cancer therapy.

Engelman JA, Settleman J.

Curr Opin Genet Dev. 2008 Feb;18(1):73-9. doi: 10.1016/j.gde.2008.01.004. Epub 2008 Mar 5. Review.

PMID:
18325754
[PubMed - indexed for MEDLINE]
4.

Inhibition of receptor tyrosine kinases in combination with chemotherapy for the treatment of breast cancer.

Moulder SL, Craft BS, Hortobagyi GN.

Anticancer Agents Med Chem. 2008 Jun;8(5):481-7. Review.

PMID:
18537531
[PubMed - indexed for MEDLINE]
5.

New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

Faivre S, Djelloul S, Raymond E.

Semin Oncol. 2006 Aug;33(4):407-20. Review.

PMID:
16890796
[PubMed - indexed for MEDLINE]
6.

Bad patients meet good drugs.

Lacal JC.

Clin Transl Oncol. 2006 Apr;8(4):225-7. No abstract available.

PMID:
16648096
[PubMed - indexed for MEDLINE]
7.

Targeted therapy for solid tumors: current status.

Zureikat AH, McKee MD.

Surg Oncol Clin N Am. 2008 Apr;17(2):279-301, vii-viii. doi: 10.1016/j.soc.2008.01.004. Review.

PMID:
18375353
[PubMed - indexed for MEDLINE]
8.

Forthcoming receptor tyrosine kinase inhibitors.

Choong NW, Cohen EE.

Expert Opin Ther Targets. 2006 Dec;10(6):793-7.

PMID:
17105367
[PubMed - indexed for MEDLINE]
9.

Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors.

Stahtea XN, Kousidou OCh, Roussidis AE, Tzanakakis GN, Karamanos NK.

Connect Tissue Res. 2008;49(3):211-4. doi: 10.1080/03008200802143307. Review.

PMID:
18661345
[PubMed - indexed for MEDLINE]
10.

The discovery and development of SU14813, a next-generation multitargeted tyrosine kinase inhibitor for the treatment of human malignancies.

Hu-Lowe D, Brega N, Patyna S.

Mol Cancer Ther. 2011 Nov;10(11):2015. doi: 10.1158/1535-7163.MCT-11-0722. No abstract available.

PMID:
22072801
[PubMed - indexed for MEDLINE]
Free Article
11.

Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain?

Di Lorenzo L.

J Clin Oncol. 2007 Jul 1;25(19):2858-9; author reply 2859-61. No abstract available.

PMID:
17602094
[PubMed - indexed for MEDLINE]
Free Article
12.

Predicting response to EGFR-tyrosine kinase inhibitors among diverse ancestries: just way too polymorphic.

Zbuk KM, Eng C.

Cancer Biol Ther. 2007 Jan;6(1):112-5. No abstract available.

PMID:
17264670
[PubMed - indexed for MEDLINE]
Free Article
13.

Targeting ERBB receptors in cancer.

Hynes NE.

Recent Results Cancer Res. 2007;172:45-57. Review. No abstract available.

PMID:
17607935
[PubMed - indexed for MEDLINE]
14.

Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors.

Hochhaus A.

Ann Oncol. 2006 Sep;17 Suppl 10:x274-9. Review. No abstract available.

PMID:
17018738
[PubMed - indexed for MEDLINE]
Free Article
15.

Successful targeted therapies for hepatocellular carcinoma: are we really getting there?

Zhu AX.

Expert Rev Anticancer Ther. 2008 Apr;8(4):499-505. doi: 10.1586/14737140.8.4.499. No abstract available.

PMID:
18402516
[PubMed - indexed for MEDLINE]
16.

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.

Jänne PA, Gray N, Settleman J.

Nat Rev Drug Discov. 2009 Sep;8(9):709-23. doi: 10.1038/nrd2871. Epub 2009 Jul 24. Review.

PMID:
19629074
[PubMed - indexed for MEDLINE]
17.

[Tyrosine kinases as targets of cancer therapy: from disbelief to Lazarus responses].

Joensuu H.

Duodecim. 2012;128(21):2261-8. Review. Finnish.

PMID:
23210289
[PubMed - indexed for MEDLINE]
18.

Mechanism of action of erbB tyrosine kinase inhibitors.

Fry DW.

Exp Cell Res. 2003 Mar 10;284(1):131-9. Review.

PMID:
12648472
[PubMed - indexed for MEDLINE]
19.

Therapeutic protein kinase inhibitors.

Grant SK.

Cell Mol Life Sci. 2009 Apr;66(7):1163-77. doi: 10.1007/s00018-008-8539-7. Review.

PMID:
19011754
[PubMed - indexed for MEDLINE]
20.

Kinase Inhibitor 4 Minisymposium summary.

Dancey JE.

Expert Rev Anticancer Ther. 2009 Jul;9(7):891-4. doi: 10.1586/era.09.66.

PMID:
19589028
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk